Herrmann T R W, Georgiou A, Bach T, Gross A J, Oelke M
Department of Urology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
Minerva Urol Nefrol. 2009 Sep;61(3):309-24.
Bladder outlet obstruction (BOO) is believed to be the major component of benign prostatic hyperplasia (BPH) that harms the urinary tract. Therefore, BOO relief is the primary treatment objective in patients with obstructive BPH. This systematic review aims to analyze urodynamic data of laser treatment modalities of the prostate in direct comparison with standard treatment (TURP or open prostatectomy). We systematically searched the literature for randomized-controlled trials (RCTs) of prostate laser treatments in which urodynamic results were compared to TURP or open prostatectomy. The literature search included articles that were published between January 1995 and January 2009. Thirty five RCTs were identified encompassing in total 3669 patients. Of all available laser treatments, only one RCT used pressure-flow data to compare the laser treatment of the prostate (holmium laser enucleation, HoLEP) with standard treatment. Improvement of maximum urinary flow rate (Q(max)) of free uroflowmetry was similar for contact laser ablation (CLAP) with Nd:YAG, interstitial laser coagulation with Nd:YAG, potassium potassium-titanyl-phosphate (KTP)/Nd: YAG hybrid treatment, and HoLEP. Qmax improvement was also similar for holmium laser ablation (HoLAP) with 60-80 Watts, holmium laser resection, and thulium laser resection but limited to only one study each. The laser hybrid therapy with CLAP/visual laser ablation of the prostate (VLAP)/Nd:YAG was inferior to TURP. VLAP and KTP showed inhomogeneous
Most contemporary laser treatments modalities provide similar Qmax improvement compared to standard treatment. However, precise differences can only be determined by comparative computer urodynamic investigations. Therefore, new laser techniques (such as thulium laser vapoenucleation of the prostate) should be investigated by urodynamic studies in the future.
膀胱出口梗阻(BOO)被认为是良性前列腺增生(BPH)损害尿路的主要组成部分。因此,缓解BOO是梗阻性BPH患者的主要治疗目标。本系统评价旨在分析前列腺激光治疗方式的尿动力学数据,并与标准治疗(经尿道前列腺电切术[TURP]或开放性前列腺切除术)进行直接比较。我们系统检索了文献中前列腺激光治疗的随机对照试验(RCT),其中将尿动力学结果与TURP或开放性前列腺切除术进行了比较。文献检索包括1995年1月至2009年1月发表的文章。共识别出35项RCT,总计3669例患者。在所有可用的激光治疗中,只有一项RCT使用压力-流量数据将前列腺激光治疗(钬激光剜除术,HoLEP)与标准治疗进行比较。钕:钇铝石榴石(Nd:YAG)接触式激光消融(CLAP)、Nd:YAG间质激光凝固、磷酸钛氧钾(KTP)/Nd:YAG混合治疗和HoLEP在自由尿流率最大尿流率(Q(max))改善方面相似。60 - 80瓦钬激光消融(HoLAP)、钬激光切除术和铥激光切除术在Qmax改善方面也相似,但每项仅涉及一项研究。CLAP/前列腺可视化激光消融(VLAP)/Nd:YAG激光联合治疗不如TURP。VLAP和KTP显示结果不均一
与标准治疗相比,大多数当代激光治疗方式在Qmax改善方面相似。然而,精确差异只能通过计算机辅助尿动力学比较研究来确定。因此,未来应通过尿动力学研究对新的激光技术(如铥激光前列腺汽化剜除术)进行研究。